Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma
Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of thymopentin on the
prevention of the recurrence and metastasis of small HCC after resection.